Egylava

AbbVie Strikes Deal to Acquire Allergan for About $63 Billion AbbVie agreed to buy the maker of Botox for about $63 billion, betting a combination will deliver new sources of growth they have struggled to find on their own.

https://www.healthcareglobal.com/pharmaceutical/leveraging-technology-and-education-high-stakes-fight-against-fake-medicines

Leveraging technology and education in the high-stakes fight against fake medicines According to new data published by the World Health Organization (WHO), one in ten medical products circulating in low and middle-income countries is either substandard or falsified. It estimates that as many as 169 000 children may die each year from pneumonia due to substandard and falsified antib...

https://www.healthcareglobal.com/supply-chain/falsified-medicines-directive-guidance-wholesalers-distributors-and-logistics-partners

The Falsified Medicines Directive: guidance for wholesalers, distributors and logistics partners Christian Taylor, Serialisation Business Consultant at Zetes looks at how the legislation aims to prevent counterfeit or unauthorised prescription medicine from entering the supply chain, providing greater protection for patients.

https://www.gov.uk/government/publications/medicines-supply-no-deal-brexit-preparation-plans-update

Medicines supply: no-deal Brexit preparation plans update The Secretary of State for Health and Social Care has written to medicine suppliers to update them on medicine supply preparations for a potential no-deal Brexit.

https://medicalxpress.com/news/2018-09-drug-prices-quickly-shortage.html

Drug prices increased twice as quickly than expected during shortage Prices for drugs under shortage between 2015 and 2016 increased more than twice as quickly as they were expected to in the absence of a shortage. While researchers could not assess reasons for the increases, manufacturers were suspected of exploiting shortages to charge more for drugs in high demand...

https://www.pharmaceutical-technology.com/news/daily-aspirin-healthy-adults/

Study finds daily aspirin does not decrease heart attack risk Initial results from ASPREE clinical trial performed to investigate the benefits and risks of low daily aspirin dose in healthy people aged above 70 years.

http://www.scoop.co.nz/stories/BU1809/S00542/thrucool-for-pharmaceutical-and-healthcare-shipments.htm

Thrucool for Pharmaceutical And Healthcare Shipments Singapore Airlines (SIA) today announced the launch of THRUCOOL, a new service to transport high-value, time-sensitive and temperature-controlled pharmaceutical cargo with speed and reliability.

http://www.pharmanews.eu/ema/1897-improving-understanding-of-biosimilars-in-the-eu

Improving understanding of biosimilars in the EU The European Medicines Agency (EMA) and the European Commission have published additional information material on biosimilar medicines, as part of their ongoing collaboration to improve understanding of biosimilars across the European Union (EU).